Found: 20
Select item for more details and to access through your institution.
Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care.
- Published in:
- International Journal of Hematology, 2012, v. 96, n. 1, p. 26, doi. 10.1007/s12185-012-1088-8
- By:
- Publication type:
- Article
A Calibration Experiment in a Longitudinal Survey With Errors-in-Variables.
- Published in:
- Journal of Agricultural, Biological & Environmental Statistics (JABES), 2010, v. 15, n. 2, p. 139, doi. 10.1007/s13253-009-0016-8
- By:
- Publication type:
- Article
Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.
- Published in:
- Journal of Oncology Pharmacy Practice, 2014, v. 20, n. 3, p. 190, doi. 10.1177/1078155213492450
- By:
- Publication type:
- Article
Assessing patients' risk of febrile neutropenia: is there a correlation between physician-assessed risk and model-predicted risk?
- Published in:
- Cancer Medicine, 2015, v. 4, n. 8, p. 1153, doi. 10.1002/cam4.454
- By:
- Publication type:
- Article
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis.
- Published in:
- BMC Health Services Research, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1472-6963-14-189
- By:
- Publication type:
- Article
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases.
- Published in:
- BMC Health Services Research, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1472-6963-13-60
- By:
- Publication type:
- Article
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC‐HF).
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 6, p. 1052, doi. 10.1002/ejhf.2181
- By:
- Publication type:
- Article
Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 4, p. 987, doi. 10.1007/s00520-012-1617-2
- By:
- Publication type:
- Article
Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 2, p. 103, doi. 10.2165/11589440-000000000-00000
- By:
- Publication type:
- Article
Staff Time and Motion Assessment for Administration of Erythropoiesis-Stimulating Agents: A Two-Phase Pilot Study in Clinical Oncology Practices.
- Published in:
- Clinical Drug Investigation, 2013, v. 33, n. 5, p. 383, doi. 10.1007/s40261-013-0078-9
- By:
- Publication type:
- Article
Rationale and Design of LAPLACE-2: A Phase 3, Randomized, Double-Blind, Placebo- and Ezetimibe-Controlled Trial Evaluating the Efficacy and Safety of Evolocumab in Subjects With Hypercholesterolemia on Background Statin Therapy.
- Published in:
- Clinical Cardiology, 2014, v. 37, n. 4, p. 195, doi. 10.1002/clc.22252
- By:
- Publication type:
- Article
Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals: Biological Insights and Treatment Implications.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Use of electronic medical records (EMR) for oncology outcomes research: assessing the comparability of EMR information to patient registry and health claims data.
- Published in:
- Clinical Epidemiology, 2011, v. 3, p. 259, doi. 10.2147/CLEP.S23690
- By:
- Publication type:
- Article
Effect of Evolocumab or Ezetimibe Added to Moderate-or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia The LAPLACE-2 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 18, p. 1870, doi. 10.1001/jama.2014.4030
- By:
- Publication type:
- Article
Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Considerations in testing treatment effects on transient event driven health status changes measured by patient reported outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial.
- Published in:
- Medical Oncology, 2012, v. 29, n. 3, p. 2291, doi. 10.1007/s12032-011-0103-x
- By:
- Publication type:
- Article